Decanoic Acid

Decanoic Acid

SCHEMBL107025

CCCCCCCCCC(=O)[O-].[K+]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Decanoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 7/20 0.76
CA1 P00915 1/20 0.71
CES2 O00748 4/20 0.67
CES1 P23141 4/20 0.67
FFAR3 O14843 1/20 0.57
HDAC3 O15379 1/20 0.57
HDAC1 Q13547 1/20 0.57
HDAC2 Q92769 1/20 0.57
HDAC8 Q9BY41 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Palmitic Acid SCHEMBL1331650 1.00 FABP3 (0.76) FABP3CA1CES2CES1FFAR3
Myristic Acid SCHEMBL14166460 1.00 FABP3 (0.76) FABP3CA1CES2CES1FFAR3
Stearic Acid SCHEMBL11360701 1.00 FABP3 (0.76) FABP3CA1CES2CES1FFAR3
Heptanoate SCHEMBL107720 1.00 FABP3 (0.76) FABP3CA1CES2CES1FFAR3
Palmitic Acid SCHEMBL1332572 1.00 FABP3 (0.76) FABP3CA1CES2CES1FFAR3
Stearic Acid SCHEMBL15533368 1.00 FABP3 (0.76) FABP3CA1CES2CES1FFAR3
Lignoceric Acid SCHEMBL6027217 1.00 FABP3 (0.76) FABP3CA1CES2CES1FFAR3
Nonadecanoic Acid SCHEMBL6026905 1.00 FABP3 (0.76) FABP3CA1CES2CES1FFAR3
Nonanoate SCHEMBL109861 1.00 FABP3 (0.76) FABP3CA1CES2CES1FFAR3
Palmitic Acid SCHEMBL19915131 1.00 FABP3 (0.76) FABP3CA1CES2CES1FFAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 920 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4253442-B1 AMINE COMPOSITION USEFUL FOR MAKING STABLE POLYURETHANE FOAM SYSTEMS EVONIK OPERATIONS GMBH (DE) 2026-04-29 EP claimed
EP-3790536-B1 NANOCONTAINERS FOR TRANSPORTING NONPOLAR, LIPOPHILIC SUBSTANCES SUCH AS ANTIBIOTICS KARLSRUHER INST TECHNOLOGIE (DE) 2026-04-22 EP claimed
US-20260028445-A1 AMINE COMPOSITION USEFUL FOR MAKING STABLE POLYURETHANE FOAM SYSTEMS EVONIK OPERATIONS GMBH (DE) 2026-01-29 US claimed
US-20250250385-A1 PRODUCTION OF POLYURETHANE OR POLYISOCYANURATE FOAM EVONIK OPERATIONS GMBH (DE) 2025-08-07 US claimed
EP-4596597-A1 PRODUCTION OF POLYURETHANE OR POLYISOCYANURATE FOAM Evonik Operations GmbH (DE) 2025-08-06 EP claimed
EP-4596596-A1 PRODUCTION OF POLYURETHANE OR POLYISOCYANURATE FOAM Evonik Operations GmbH (DE) 2025-08-06 EP claimed
EP-4562069-A1 TERTIARY AMINO-AMIDE COMPOSITION USEFUL IN MAKING POLYURETHANE POLYMERS Evonik Operations GmbH (DE) 2025-06-04 EP claimed
EP-4562070-A1 METHOD FOR PREPARING FLEXIBLE SLABSTOCK POLYURETHANE FOAM Evonik Operations GmbH (DE) 2025-06-04 EP claimed
EP-4538340-A1 FOOD SAFE AQUEOUS INKJET COMPOSITIONS Canon Production Printing Holding B.V. (NL) 2025-04-16 EP claimed
CN-119630722-A Tertiary amino-amide compositions useful in the manufacture of polyurethane polymers 赢创运营有限公司 2025-03-14 CN claimed
EP-1648851-A2 PREPARATION OF METAL SALTS OF MEDIUM-CHAIN FATTY ACIDS Prometic Biosciences Inc. (CA) 2006-04-26 EP claimed
WO-2006024174-A1 SUBSTITUTED PURINYL DERIVATIVES WITH IMMUNOMODULATOR AND CHEMOPROTECTIVE ACTIVITY AND USE ALONE OR WITH MEDIUM-CHAIN LENGTH FATTY ACIDS OR GLYCERIDES PROMETIC BIOSCIENCES INC. (CA) 2006-03-09 WO claimed
WO-2005012217-A2 PREPARATION OF METAL SALTS OF MEDIUM-CHAIN FATTY ACIDS PROMETIC BIOSCIENCES INC. (CA) 2005-02-10 WO claimed
US-20030034586-A1 Method for producing ceramic structure NGK INSULATORS, LTD. (JP) 2003-02-20 US claimed
EP-1258331-A1 METHOD FOR PRODUCING CERAMIC STRUCTURE NGK INSULATORS, LTD. (JP) 2002-11-20 EP claimed
US-5302486-A Encapsulated toner process utilizing phase separation XEROX CORPORATION (US) 1994-04-12 US claimed
US-5283153-A Encapsulated toner processes XEROX CORPORATION (US) 1994-02-01 US claimed
US-5223370-A Low gloss toner compositions and processes thereof XEROX CORPORATION (US) 1993-06-29 US claimed
US-5175071-A Encapsulated toner composition XEROX CORPORATION (US) 1992-12-29 US claimed
US-3960908-A AQUEOUS EMULSIONS CONTAINING SILVER SALT, SALT OF CARBOXYLIC ACID AND SOLVENT FUJI PHOTO FILM CO., LTD. (JA) 1976-06-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028445-A1 AMINE COMPOSITION USEFUL FOR MAKING STABLE POLYURETHANE FOAM SYSTEMS RFC2, RFC3, PUF60 FABP3 3396/4885CA1 1294/4885CES2 1219/4885
US-20250250385-A1 PRODUCTION OF POLYURETHANE OR POLYISOCYANURATE FOAM PUF60, PARN, SLC39A11 FABP3 2796/4885CA1 514/4885CES2 1117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.